David C. U'Prichard Net Worth & Insider Trades

David C. U'Prichard - Director, Cyclacel Pharmaceuticals, Inc

As of June 29, 2020

What is David C. U'Prichard's Net Worth?

The current estimated net worth of Cyclacel Pharmaceuticals, Inc's Director, David C. U'Prichard, is estimated to be about $12.79K . David C. U'Prichard owns about 20,306 units of Cyclacel Pharmaceuticals, Inc common stock. In the last 14 years at Cyclacel Pharmaceuticals, Inc, David C. U'Prichard has sold an estimated value of $0 worth.

What is David C. U'Prichard's Past Insider Trading?

David C. U'Prichard's largest purchase order was 960 units , worth over $5.68K on September 15, 2006. In total, David C. U'Prichard has made about 13 transactions over 14 years of their time at Cyclacel Pharmaceuticals, Inc. David C. U'Prichard usually trades in May, with the busiest year in 2006.

David C. U'Prichard

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is David C. U'Prichard's' Mailing Address?

  • Mailing address is 12 Pine Street Philadelphia PA 19106 PA

What are Cyclacel Pharmaceuticals, Inc's Past Insider Trades?

Cyclacel Pharmaceuticals, Inc's most recent insider trade came on December 2, 2021 by Sam L Barker who sold 12 units worth $42.86 . In the last 15 years, insiders at Cyclacel Pharmaceuticals, Inc have sold an estimated value of $7.67M and bought an estimated value of $14.98M worth of shares. Insider trading is most common in May, with the busiest year in 2008. The most active traders at the company are Spiro Rombotis, President and CEO,  Morgan Stanley,  and David C. U'Prichard, Director .

Cyclacel Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...